Conjunctivitis - 118 Studies Found

Completed : Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
: Keratoconjunctivitis Sicca
: 2002-05-18
: Drug: INS365 Ophthalmic Solution
Completed : A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
: Keratoconjunctivitis Sicca
: 2016-01-20
:
  • Drug: 1% Tavilermide Ophthalmic Solution

Completed : TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
: Keratoconjunctivitis Sicca
: 2009-02-18
Completed : A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome
: Keratoconjunctivitis Sicca
: 2014-04-17
:
  • Drug: SkQ1
  • Drug: Placebo SkQ1 (Vehicle)
Withdrawn : A Study Of Tasocitinib In Dry Eye Subjects
: Keratoconjunctivitis Sicca
: 2010-10-20
:
  • Drug: Tasocitinib 0.005% QD fo
Completed : Trial of CF101 to Treat Patients With Dry Eye Disease
: Keratoconjunctivitis Sicca
: 2010-11-03
: Drug: CF101 orally q12h Other Name: IB-MECA
Completed : Dry Eye Assessment and Management: Feasibility Study
:
  • Dry Eye Syndromes
  • Keratoconjunctivitis Si
    : 2010-04-09
    :
    • Drug: Omega-3 EFA Supplement

Completed : Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE)
:
  • Dry Eye
  • Keratoconjunctivitis Sicca
    : 2011-08-17
    :
    • Drug: Lifitegrast Dosage Form:
Completed : Ocular Surface Dry Eye Microbiome
: Dry Eyes
: 2014-12-01
Active, not recruiting : The Role of Cytokines and Mast Cell in the Pathogenesis of SLK, Conjunctivochalasis, and Dry Eye
:
  • Superior Limbic Keratoconjunctivitis
  • Conjunctivochalasis
    • <
    : 2014-05-27
<<< Previous | Next >>>